These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1048 related items for PubMed ID: 16681663

  • 1. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR, Schulze KE, Nelson BR.
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [Abstract] [Full Text] [Related]

  • 2. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R.
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [Abstract] [Full Text] [Related]

  • 3. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, Neumann HA.
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [Abstract] [Full Text] [Related]

  • 4. Superficial basal cell carcinomas of the head and neck.
    Mina MA, Picariello A, Fewkes JL.
    Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
    [Abstract] [Full Text] [Related]

  • 5. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD, Parlette HL.
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [Abstract] [Full Text] [Related]

  • 6. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R.
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [Abstract] [Full Text] [Related]

  • 7. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
    Holmkvist KA, Rogers GS, Dahl PR.
    J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
    [Abstract] [Full Text] [Related]

  • 8. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC.
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [Abstract] [Full Text] [Related]

  • 9. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I, Huilgol SC, Richards S, Paver R, Selva D.
    Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
    [Abstract] [Full Text] [Related]

  • 10. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
    Angulo J, Serra-Guillén C, Traves V, Botella-Estrada R, Sanmartín O, Llombart B, Requena C, Guillén C, Nagore E.
    Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
    [Abstract] [Full Text] [Related]

  • 11. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R.
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [Abstract] [Full Text] [Related]

  • 12. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
    van Baardwijk AA, Verhaegh ME, Krekels GA, Vermeulen AH, Neumann HA.
    Ned Tijdschr Geneeskd; 1997 Mar 15; 141(11):524-9. PubMed ID: 9190509
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, Neumann HA.
    Arch Dermatol; 2006 Feb 15; 142(2):187-94. PubMed ID: 16490846
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T, Woitek M, Eichhorn K, Simon JC, Paasch U.
    Dermatology; 2010 Feb 15; 220(4):363-9. PubMed ID: 20484877
    [Abstract] [Full Text] [Related]

  • 16. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
    Aoyagi S, Nouri K.
    Dermatol Surg; 2006 Nov 15; 32(11):1375-9. PubMed ID: 17083591
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision.
    Cohen PR, Schulze KE, Nelson BR.
    South Med J; 2005 Jul 15; 98(7):740-7. PubMed ID: 16108247
    [Abstract] [Full Text] [Related]

  • 18. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL, Garrod DR, Viehman GE, Madani S, Buchanan MD, Clark RE.
    Dermatol Surg; 1997 Jun 15; 23(6):463-8. PubMed ID: 9217798
    [Abstract] [Full Text] [Related]

  • 19. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
    Florell SR, Layfield LJ, Gerwels JW.
    J Am Acad Dermatol; 2001 Apr 15; 44(4):660-4. PubMed ID: 11260543
    [Abstract] [Full Text] [Related]

  • 20. An assessment of incomplete facial Basal cell carcinoma excision.
    Shah SA, Obaidullah, Fahimullah.
    J Coll Physicians Surg Pak; 2005 Mar 15; 15(3):149-51. PubMed ID: 15808092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.